Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 15 April 2021
      Catch up on EFPIA's Podcast Series: 19 Conversations
 
  25 March 2021 Podcast: Should Europe relocate pharmaceutical production to within the EU?

Welcome to 19 conversations

Read more →
 
 
 
  24 March 2021 Podcast: How can monoclonal antibodies help in the fight against COVID-19?

Welcome to 19 Conversations

Read more →
 
 
 
      From our blog
 
  14 April 2021 ‘EUnited’ in Diversity (Guest blog)

Healthcare Sector Evolution to #EUnite Healthcare Ecosystem

Read more →
 
 
 
  13 April 2021 IMI Impact: progress driven by partnership (Guest blog)

The Innovative Medicines Initiative is tackling the biggest health issues of our time through collaborations that make...

Read more →
 
 
 
      Missed our previous events? Rewatch on EFPIA's YouTube channel
 
 
 
Are current investments in medical research focusing on unmet health needs?
To coincide with the publication of EFPIA’s annual “Pipeline Review”, EFPIA held a high-level panel discussion around the latest medical research outcomes, joined by representatives from patient organisations, EU institutions, and industry. Read more: https://efpia.eu/news-events/the-efpi...
 
 
Unlocking the Potential of Precision Medicine in Europe
The International Quality Network for Pathology (IQN Path), the European Cancer Patient Coalition (ECPC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) jointly share the findings from the study “Unlocking the potential of precision medicine in Europe – Improving cancer care through broader access to quality biomarker testing”.
 
 
 
 
      Events
 
 
26 APR 2021
  Launch of the IP Principles for Advancing Cures and Therapies (IP PACT) Virtual event

Launching the IP PACT: Our approach to Intellectual Property with patient and societal benefit at its core

Learn more →
 
 
 
25 MAY 2021
  Unlocking the potential of the European Health Data Space to improve diabetes management... Virtual event

The first in a two-part series co-hosted by the EFPIA Diabetes Platform and the European Diabetes Forum (EUDF)

Learn more →
 
 
      What we are reading
Join the EFPIA team: Senior Manager Public Affairs 15 April 2021  (EFPIA) Read more →
Pfizer’s boss thinks covid-19 is reshaping Big Pharma for the better 10 April 2021  (The Economist) Read more →
Commission opens first European Innovation Council calls worth €1 billion 09 April 2021  (European Commission) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe